Skip to content
Meridian Pharmaceuticals

Meridian Pharmaceuticals

LargeClaudia HofmannClaudia Hofmann · Global Head, Reg Submissions KB v1
Open full session

Deal stage

— where this deal is in its journey, first contact to close
ProspectJul 3, 2026 • 8:50 PM
Engaged
Qualified
Meeting Booked
Closed LostJul 4, 2026 • 2:28 PM

Deal snapshot

Win chance, the value at stake, and how far this deal has come.

Win chance

0%to close

Weighted to $0

Value at stake

Full value vs. risk-adjusted.

Pipeline progress

5/5stage

Closed Lost · 18d since touch

Pre-call brief

Meridian Pharmaceuticals is in Closed Lost — $815K open, weighted to $0 at 0% win odds. Recommended next move: Stabilize Meridian Pharmaceuticals.

StageClosed Lost · 0% win probability.
Value$815K open, $0 weighted.
Momentum18 days since the last activity.
Next stepNothing scheduled — set the next step.

Recommended: Stabilize Meridian Pharmaceuticals

A quick read on this deal from your agent — where it stands and the smartest next move — so you're prepared before you call or email. The agent never reaches out on its own.

Deal value

$815K

The full amount if it closes.

Weighted

$0

0% chance of closing

Owner

Suren DheenSuren Dheen

Who's running this deal — that's you.

Last activity

Jul 4, 2026 • 2:28 PM

Your most recent logged call, email, or note — 18 days ago.

Agent — next best action for this deal

Meridian Pharmaceuticals

Stabilize Meridian Pharmaceuticals

Meridian Pharmaceuticals's health has slipped to 35/100 — negative last touch. Step in with a stabilizing touch before the relationship cools.

View

Recommended Services

Regulatory Submission Services90%

Position Regulatory Submission Services against Meridian Pharmaceuticals's near-term regulatory milestones.

Regulatory Intelligence70%

Single-pane monitoring across FDA, EMA and 120+ agencies.

Activity

  1. Not Interested
    Jul 4, 2026 • 2:28 PM

    Has incumbent vendor mid-contract.

    Suren DheenLogged by Suren Dheen